[What is the value of therapy with dihydroergotamine plus etilefrin in orthostatic circulation disorders].
D000293:Adolescent; D000328:Adult; D000368:Aged; D004087:Dihydroergotamine / Q000627:therapeutic use*; D005039:Etilefrine / Q000627:therapeutic use*; D006801:Humans; D007024:Hypotension, Orthostatic / Q000188:drug therapy*; D008875:Middle Aged; D010656:Phenylephrine / Q000031:analogs & derivatives*; D010919:Placebos
D010919:Placebos; D010656:Phenylephrine; D004087:Dihydroergotamine; D005039:Etilefrine
Welchen Wert besitzt die Therapie orthostatischer Kreislaufstörungen mit einer Kombination aus Dihydroergotamin plua Etilefrin?